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SHORT COMMUNICATIONS
Chemical Immobilization of Red Foxes
(Vulpes vulpes)
95
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Terry J. Kreeger, Ulysses S. Seal,2 and John R. Tester, 1 Department of Ecology and Behavioral Biology,
University of Minnesota, Minneapolis, Minnesota 55455, USA; 2Veteran’s Administration Medical Center, Minneapolis,
Minnesota 55417, USA
ABSTRACT: Red foxes (Vulpes vulpes) were
immobilized with one of the following drug
combinations: ketammne/xylazine (n = 22), ke-
tamine/promazine (n = 35), ketamine/mida-
zolam (n = 13), or tiletammne/zolazepam (n =
22). Foxes given ketammne/xylazine had the
shortest induction and longest recovery times
relative to other drug combinations, whereas
foxes given ketamine/midazolam had the lon-
gest induction times. Recommended doses for
the various combinations are given. Foxes given
ketammne/xylazmne were given either 0.1, 0.2,
0.4 mg/kg yohimbmne, or saline 40 mm after
anesthetic induction. Administration of yoh-
imbine significantly shortened arousal and re-
covery times relative to control values (P <
0.001).
Key words: Red fox, Vulpes vulpes, chemi-
cal immobilization, ketamine HCL, xylazine
HCL, midazolam HCL, promazine HCL, tile-
tamine, zolazepam, yohimbmne HCL, experi-
mental study.
Red foxes (Vulpes vulpes) have been
immobilized with phencyc!idmne and
promazine (Seal et a!., 1970) or ketamine
and xy!azmne (Jessup, 1982). Newer im-
mobilizing agents or antagonists have been
used successfully on a variety of wild
species. We report on the use of some of
these newer agents and compare the effi-
cacy of different drug combinations on
captive red foxes.
This study was conducted from August
1985 through February 1989. Young (8-
to 12-wk-old) fox pups were excavated
from their dens in east central North Da-
kota (47#{176}10’to 47#{176}20’N, 98#{176}45’to 99#{176}15’W)
and maintained as family units in kennels
equipped with den boxes. Foxes were fed
frozen commercial canine food (Lang
Packing, St. Cloud, Minnesota 56080, USA)
and provided water ad libitum. Al! animals
were vaccinated for rabies, canine distem-
per, canine parvovirus, infectious canine
hepatitis, leptospirosis, and parainfluenza
(TechAmerica#{174}, Fermenta Animal Health,
Omaha, Nebraska 68134, USA). Al! were
periodically treated for ecto- and endo-
parasites (Ivomec#{174}, Merck, Inc., Rahway,
New Jersey 07065, USA). At 4 to 5 mo of
age (juvenile), each animal was paired with
an unrelated mate and the pair housed
separately. At 7 to 10 mo of age (subadult),
a pair was selected for surgical implanta-
tion of a heart rate/body temperature ra-
dio transmitter (Cedar Creek Bioe!ectron-
ics Laboratory, East Bethel, Minnesota
55011, USA) (Kreeger et a!., 1989a). With
the exception of Group One below, the
anesthetic protocol selected was used for
the purpose of implantation of these trans-
mitters. After anesthetic induction, all fox-
es were weighed and blood samples were
taken from the jugular vein.
Induction time (IT), head-up time
(HUT), and walk time (WT) were defined.
IT was time from injection of anesthetic
to loss of consciousness. HUT was time
from IT to spontaneous movement of the
head. WT was time from IT until the an-
imal could walk in a directed, coordinated
manner, but not necessarily judged be-
haviora!ly “normal.”
Seventy foxes were used in this study.
Group One consisted of 22 juveniles foxes
(11 males, 11 females) subdivided into four
mixed-sex subgroups of five to six animals.
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TABLE 1. Recovery times for 4- to 5-mo-old red foxes immobilized with ketamine and xylazine and given
either yohimbine or 0.9% saline intravenously 40 mm after induction. Means are reported with standard
errors.
Yohimbine do so (mg/kg)
0 (control) 0.1 0.2 0.4
n 6 5 5 5b
Head-up time (mm) 86.2 ± 12.1’ 6.4 ± 3.6 8.8 ± 2.4 1.6 ± 0.4
Walk time (mm) 143.8 ± 28.6’ 33.2 ± 14.3 38.6 ± 8.8 35.4 ± 10.3
Significantly different from all other doses (P < 0.05).
Data do not include one death.
A!! were physically restrained and injected
intramuscularly with 70 to 100 mg ketarn-
me hydrochloride (HCL) (KET; Ketaset#{174},
Bristol Laboratories, Syracuse, New York
13221, USA) and 4 to 5 mg xy!azine HCL
(XYL; Rompun#{174}, Miles Laboratory Inc.,
Shawnee, Kansas 66201, USA). Approxi-
mately 40 mm after induction, the
subgroups were given either 0.1, 0.2, 0.4
mg/kg yohimbine HCL (YOH; Sigma
Chemical Co., St. Louis, Missouri 63178,
USA) or a comparable volume of sterile
0.9% NaCl intravenously (controls). Prep-
aration of YOH was described by Kreeger
and Sea! (1986a). Statistical analyses for
Group One data were based on one-way
A NOVA at a significance level of P <0.05.
Means are reported with standard errors
(SE). Group Two consisted of 35 subadult
foxes (18 males, 17 females), 22 of which
were from Group One used 3 to 5 mo
previously. Foxes were physically re-
strained and injected intramuscularly with
100 to 150 mg KET and 25 mg promazine
HCL (PRO; Sparine#{174}, Wyeth Labs, Phila-
delphia, Pennsylvania 19101, USA). Group
Three consisted of 13 different subadult
foxes (7 males, 6 females) which were
physically restrained and injected intra-
muscularly with 125 to 150 mg KET plus
2.5 mg midazo!am HCL (MID; Versed#{174},
Roche Laboratories, Nut!ey, New Jersey
07110, USA). Group Four consisted of 22
other subadult foxes (11 males, 11 females)
which were physically restrained and in-
jected intramuscularly with 40 to 55 rng
each of tiletamine HCL (TIL) and zo!a-
zepam HCL (ZOL) (Telazol#{174}, A. H. Ro-
bins, Richmond, Virginia 23220, USA).
The HUT and WT for foxes given YOH
was significantly shorter than for control
foxes (P = 0.0001 and 0.001, respectively;
Table 1). There was no difference in HUT
or WT among YOH doses (P = 0.94). Cata-
leptoid muscle rigidity and tremors usually
followed intravenous YOH administra-
tion. One male fox who received 0.2 mg/
kg YOH and one female who received 0.4
mg/kg YOH had recta! temperatures of at
least 43.3 C during this period. Both foxes
were immersed in water after body tem-
perature was measured, but only the male
survived. Ambient temperature during this
episode was about 33.0 C. In genera!, re-
coveries in foxes given YOH were char-
acterized by increased activity as the an-
imal attempted to become sterna! and
stand. The foxes would often raise their
heads only to drop them with some force
for a period of time prior to becoming
sterna! or standing.
Statistical analyses were not performed
on data among groups since foxes were not
randomly assigned and because two age
groups were used. Induction times ap-
peared to differ among a!! four groups with
Group One foxes recording relatively short
IT and Group Three relatively long IT
(Table 2). Group One tended to have a
longer HUT compared to the other groups.
Inductions for all drug combinations were
smooth, as were recoveries with the ex-
ception of Group One foxes given YOH.
Recoveries without YOH were character-
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TABLE 2. Induction and arousal times for red foxes immobilized with either ketamine/xylazine, ketamine/
promazine, ketamine/midazolam, or tiletamine/zolazepam. Means are reported with standard errors.
Group n Drug combination Amount (mg/kg) Induction time (mm) Head-up t ime (mm)
1 22’ Ketamine
Xylazine
22.7 ± 0.6
1.2 ± 0.03 1.4 ± 0.1 86.2 ± 1.21
2 35h Ketamine
Promazine
27.9 ± 0.1
5.2 ± 0.1 2.7 ± 0.2 27.3 ± 0.3
3 13 Ketamine
Midazolam
30.8 ± 1.2
0.6 ± 0.02 4.9 ± 0.7 18.6 ± 4.0
4 22h Tiletamine
Zolazepam
5.3 ± 0.2
5.3 ± 0.2 3.6 ± 0.5 25.1 ± 2.5
‘Juvenile (4 to 5 mo) foxes.
Suhadult (7 to 10 mo) foxes.
Head-up time for Group One foxes receiving saline only (n = 6).
ized by tremors, but not the increased ac-
tivity seen after YOH administration.
The relationship between YOH dose and
HUT and WT in red foxes was similar to
that reported for gray wolves (Canis lu-
pus) (Kreeger et a!., 1987); increasing the
YOH dose did not shorten recovery times.
Higher doses of YOH are probably con-
traindicated due to the extreme tachycar-
dia seen in canids immobilized with ke-
tamine and xylazine then given doses of
YOH  0.2 mg/kg (Kreeger et a!., 1987).
The positive chronotropic effects of both
KET (Folts et a!., 1975) and YOH (Gomes
et a!., 1980) apparently act synergistically
to markedly increase heart rate, since this
tachycardia is not seen when YOH is given
to animals anesthetized with drugs other
than KET (Kreeger et a!., 1989b).
Another caution in the use of YOH in
animals anesthetized with KET and XYL
is the time of YOH administration after
the last KET injection. Yohimbine is an
a!pha2-adrenergic antagonist (Goldberg
and Robertson, 1983) which acts on pre-
synaptic adrenoceptors to antagonize the
effects of XYL (Langer, 1981). Yohimbine
does not antagonize KET anesthesia (Kree-
ger and Seal, 1986b). For a smooth recov-
ery, sufficient time must be allowed for
the animal to metabolize KET prior to
YOH administration. If the effects of XYL
were antagonized through the use of YOH
before sufficient KET had been metabo-
lized, the animal would recover from what
is effectively pure KET anesthesia. Rough
induction and recovery effects of KET
alone have been we!! documented (Wright,
1982). We feel that the two cases of hy-
perthermia were caused by this phenom-
enon, coupled with warm ambient tem-
peratures that resulted in a rapid increase
in endogenous heat production.
The relationship between different drug
combinations confirmed our empirical ob-
servations with canid immobilizations over
the years. That is, the combination of KET
and XYL results in rapid induction cou-
pled with extended recovery times if YOH
is not administered. Likewise, it has been
our experience with wolves (T. J. Kreeger,
unpub!. data) that KET combined with
MID resulted in extended induction times
while arousal times were short, often re-
quiring boosters of KET to maintain anes-
thesia. The combinations of KET and PRO
or TIL and ZOL achieved quick induc-
tions and acceptable recovery times in red
foxes and appeared to be good drug com-
binations to use on this species. These two
drug combinations also provide good car-
diovascular and respiratory support com-
pared to the potential bradycardic, hy-
potensive and respiratory depressant effects
of XYL (Clark et a!., 1982). While KET
can induce convulsions in canids (Wright,
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1982), only one convulsion in 70 trials was
noted in this study. This occurred in a fe-
male fox anesthetized with KET and PRO.
If convulsions are unacceptable, we would
recommend the use of either KET/MID
or TIL/ZOL as both of these combinations
benefit from the anticonvulsant effects of
benzodiazepine tranquilizers (Richter,
1981).
Based on these results and our experi-
ence with wild canid anesthesia, we rec-
ommend the following dosages for im-
mobilization of red foxes: (1) 30 mg/kg
ketamine plus 5 mg/kg promazine; (2) 20
mg/kg ketamine plus 1 mg/kg xylazine;
0.1 mg/kg yohimbine given 45 to 60 mm
after the last ketamine administration; (3)
30 mg/kg ketamine plus 1 mg/kg mida-
zolam; or (4) 5 mg/kg ti!etamine plus 5
mg/kg zo!azepam (i.e., 10 mg/kg of Tel-
azol#{174}).
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